PROGRAM

Silfurberg A

Session 7

Severe asthma

Chair I: Dóra Lúðvíksdóttir (Iceland)

Chair II: Charlotte Ulrik (Denmark)

08:30-08:50

“Learnings from Nordstar” a summary of the key findings from Nordic data on severe asthma. (eosinophil vs non eosinophilic asthma)

Lauri Lethimaki (Finland)

08:50-09:10

Multimorbitity  in severe asthma

Ramesh Kurukulaaratchy  (England)

09:10-09:30

Reframing Remission in Severe Asthma - distinguishing disease activity vs damage or The Biology of remission on Biologics

Celeste Porsbjerg (Denmark)

09:30- 09:50

Severe asthma and remission prospects in Europe: insights from SHARP

Apostolos Bossios (Sweden)

09:50-10:00

Questions

Silfurberg B

Session 8

Lung Cancer Screening

Chair I: Hrönn Harðardóttir (Iceland)

Chair II: Stefan Barrath ( Sweden)

08:30-08:55

Organised Targeted Population Screening for Lung Cancer in the UK

David Baldwin (England)

08:55-09:10

Screening in Norway and risk models for selection

Oluf Dimitri Roe (Norway)

09:10 - 09:25

How to achieve a high participation rate in lung cancer screening - experience from the Estonian pilot study

Tanel Laisaar  (Estonia)

09:25-9:40 

Screening in Sweden

Gunnar Wagenius (Sweden)

09:40 - 10:00

Panel discussions

 Kaldalón

Session 9

Respiratory insufficiency

Chair I: Friðrik Yngvason (Iceland) 

Chair II: Christina Due Svendsen (Norway)

08:30-08:50

Use of NHFT  in chronic respiratory failure

Line Storgaard (Denmark)

08:50-09:20 

LTOT and hypoxemia is less better?

Magnus Ekström (Sweden)

09:20-09:40

Lung diseases and acute respiratory failure: when to intubate and the challenges in treatment.

Helga Ásgeirsdóttir (Sweden)

09:40-10:00  

Panel discussion

Ríma

Nurse session 1

Nurse-Patient Relationship

Chair: Helga Jónsdóttir (Iceland)

8:30 - 9:00

Stigma and Vulnerability in the Care of Patients with COPD

Heidi Jerpseth (Norway)

9:00 - 9:20

Relational Continuity in COPD Care: Insights from Patients in Swedish Primary Care. A qualitative study

Sara C. Roos (Sweden)

9:20 - 9:40

Understanding COPD-related anxiety: Experiences of patients, caregivers and healthcare professionals

Camilla F. Christiansen (Denmark)

9:40 - 10:00

Co-Creating a Differentiated Intervention for People with COPD in Socially Vulnerable Situations

Nanna V. Gregersen (Denmark)

10:00 - 10:10

Discussions

Poster round 4 - Lung function and airways disease

Chair: Tomas Eagan

P04-1 - Adherence to national asthma and COPD non-pharmacological  guidelines: Insights from the Swedish National Airway register

Caroline  Stridsman (Sweden)

P04-2 - International delphi study on interpreting respiratory oscillometry in adults with asthma or COPD

Ingvild Bjellmo Johnsen (Sweden)

P04-3 - Study protocol: Effect of a Smart Inhaler Add-On on Adherence and Inhaler Technique in Patients with Poorly Controlled Asthma

Jonas Aggerholm Bækd (Denmark)

P04-4 - Obstructive lung disease in an adult with prior bronchopulmonary dysplasia

Weiling Lim (Singapore)

P04-5 - Spirometry and care of people with lung diseases in primary health care in Iceland 2018-2021

Arna  Hilmarsdóttir (Iceland)

Poster round 5 - Lung cancer 

Chair: Anders Blomberg 

P05-1 - Multidisciplinary Team Meetings for Lung Cancer in the Nordic Countries: Results from a Nordic Survey

Anja Gouliaev (Denmark)

P05-2 - Ultrasound-guided pleural biopsy in the diagnosis of pleural mesothelioma: Results from a large, multicenter, Danish cohort study

Vasiliki Panou (Denmark)

P05-3 - Title: Diagnostic utility of Checkpoint kinase 1 (CHK1) immunostaining in pleural effusion cytology for pleural mesothelioma (PM)

Azadeh Asghari Birbaneh (Denmark)

P05-4 - Building trust in AI among clinicians

Atle Rosendahl-Riise (Norway)

P05-5 - COPD diagnosis during lung cancer evaluation: A scoping review of existing evidence

Ditte Krag-Hansen (Denmark)

Poster round 6 - Interstitial lung disease 

Chair: Össur Ingi Emilsson

P06-1 - Lung function trajectories before and after antifibrotic therapy in progressive pulmonary fibrosis

Nanna Makholm Østergård (Denmark)

P06-2 - Extent and survival of Progressive Pulmonary Fibrosis in Patients with Fibrotic Interstitial Lung Disease: a Danish Cohort Study

Line Kølner-Augustson (Denmark)

P06-3 - Informal carers’ roles: a mixed-methods study comparing views of people with interstitial lung diseases, informal carers, and healthcare professionals

Raquel Vilar Marinho (Portugal)

P06-4 - Increased risk of fibrotic interstitial lung disease and prescription of antifibrotics after serious COVID-19 illness

Emil Ekbom (Sweden)

P06-5 - MUC5B Variants and Survival Outcomes in Pulmonary Fibrosis: Associations with Lung Function and Clinical Phenotype

Mari Ainola (Finland)

Silfurberg A

Session 10

Sanofi - Symposium

10:30-11:55

ASTHMA AND COPD
with Type 2 Inflammation:

What Matters in Clinical Practice?

Moderator: Unnur Björnsdóttir (Iceland)

Speakers:
Klaus Rabe and
Brian Lipworth

Silfurberg B

Session 11

Pulmonary hypertension

Chair I: Sif Hansdóttir (Iceland)

Chair II: Rainer Böger (Germany)

10:30-11:00

Risk stratification and treatment goals in PAH - Reflections on the new          WSPH treatment algorithm

Göran Rådegran (Sweden)

11:00-11:30

Borderline or Overlap? Defining PH Phenotypes in Patients With Multiple Comorbidities

Clara Hjalmarsson (Sweden)

11:30-12:00

From Clot to Cure: Modern Management of CTEPH

Sören Mellemkjær (Denmark)

Kaldalón

Session 12

Pulmonary Rehabilitation: Accessibility, participation and maintenance

Chair I: Anders Løkke (Denmark) 

Chair II:  Hans Jakob Beck (Iceland)

10:30-11:00

Referral, uptake, adherence and maintenance

Margareta Emtner (Sweden)

11:00-11:20

Home-based and tele-rehabilitation programmes for socially or geographically isolated patients

Henrik Hansen (Denmark)

11:20-11:40

Long-term maintenance training in Iceland

Ragnheiður Harpa Arnardóttir (Iceland)

11:40-12:00

Panel discussion

Ríma

Nurse session 2

Patients’ Experiences of Treatments

Chair: Þorbjörg Sóley Ingadóttir  ( Iceland)

10:30 - 11:00

Everyday life with Ambulatory Oxygen Treatment in Patients with COPD

Ann Ekdahl (Sweden)

11:00 - 11:30

Telehealth for patients with COPD-Birgit Refsgaard Iversen

Birgit Refsegaard Midjord (Denmark)

11:30 - 11:50

Asthma/COPD clinics in primary care adherence to non-pharmacological management guidelines in patients with COPD

Jenny Nilsson (Sweden)

11:50 - 12:00

Discussions

RÍMA

Nordic collaboration in Respiratory Nursing

Chair: Helga Jónsdóttir

Silfurberg A

Session 13

COPD

Chair I: Benedikt Friðriksson (Iceland)

Chair II: Christer Jansson (Sweden)

13:00-13:20

Dyspnea in COPD: mechanisms, measurement and management

Magnus Ekström (Sweden)

13:20-13:40

Application of endobronchial valves in treatment of COPD

Lowie Vanfleteren (Sweden)

13:40-14:00

Use of biologics in treatment of COPD

Lowie Vanfleteren (Sweden)

14:00-14:20

On the importance of vaccinations in patients with COPD - a 2026 update.

Eva van Braeckel (Belgium)

Silfurberg B

Session 14

Bronchiectasis

Chair Inga Sif Ólafsdóttir (Iceland)

Chair II: Sólrún Björk Rúnarsdóttir (Iceland)

Case based interactive session with multidisciplinary panel

Panel:
Kristján Orri Helgason, Birgir Jóhannsson, Ragnheiður Harpa Arnarsdóttir

Speakers:
Stella Rún Guðmundsdóttir, Óskar Jóel Jónsson

Kaldalón

Session 15

Lung transplantation

Chair I: Sif Hansdóttir (Iceland)

Chair II: Hans Henrik Lawaetz Schultz (Denmark)

13:00- 13:30

„A perfect match?“

Sigrún Ásgeirsdóttir (Iceland)

13:30-14:00

ABC, CLAD and the proposed other LAD‘s

Jesper Magnusson (Sweden)

14:00-14:30

Lung transplantation surgery, new technology

Per Martin Silverborn (Sweden)

RÍMA

Oral session 2

Asthma /sleep apnea

Chair I: Duco Daniel Deenstra (Iceland)

Chair 2: Sigurður Þór Sigurðarson (Iceland)

13:00-13:10 

High cough counts in elite cross-country skiers during a World Cup weekend

Rikhard Måki-Heikkilå, Tampere University

13:10-13:20

Treatment with biologics ameliorates serum hepcidins’ levels in severe eosinophilic asthma

Alan Altraja, Department of Pulmonology, Insitute of Clinical Medicine, University of Tartu

13:20-13:30

Dupilumab improves large and small airway function and improves persistent airflow obstruction in patients with moderate-to-severe asthma from VESTIGE

Brian Lipworth, Sanofi

13:30-13:40 

Switch to remission: secondary remission to anti-IL4/13 treatment after treatment failure on anti-IL5/Ra in severe asthma – a nationwide cohort study

Kjell Erik Julius Håkansson, Copenhagen University Hospital

13:40-13:50 

Healthcare utilization before and after biologic therapies in severe asthma and CRSwNP: real-world data from Helsinki, Finland

Emilia Ylkånen, Allergy Department, Skin and Allergy Hospital, Helsinki University Hospital

13:50-14:00 

Sleep apnoea in patients undergoing colorectal cancer surgery: Prospective cohort study

Karl A Franklin, Umeå University Hospital

14:00-14:10

Distribution figures of particles in exhaled air (PExA)  -  a new biological fingerprint assessed with AI ?

Maria Juusela Medical Center AAVA and Pikkujåtti

Poster round 7 - Asthma – Guideline adherence and clinical treatment effects   

Chair: Benedikt Friðriksson

P07-1 - Asthma symptoms and GINA treatment steps in Sweden and Finland

Elias Benjamin Nurmi (Finland)

P07-2 - Long-term exacerbation trends before and after initiating triple therapy for uncontrolled asthma

Ingvild Bjellmo Johnsen (Sweden), Nicolas  Roche (France), David Price (Singapore)

P07-3 - LAMA Use in Asthma Management: Insights from the EU-LAMA Study with a Focus on Sweden

Christer Janson (Sweden)

P07-4 - Clinical remission in patients with asthma treated with twice-yearly depemokimab in the Phase III SWIFT-1/2 studies

Michael E  Wechsler (United States)

P07-5 - Inhaled corticosteroid use and self-reported voice problems in a Nordic population-based cohort

Sofia Ögefeldt (Sweden)

Poster round 8 - COPD – Exacerbations, hospitalizations, and mortality

Chair: Christer Janson

P08-1 - Association of single- vs multiple-inhaler triple therapy with adherence and exacerbation risk in COPD: A nationwide cohort study in Denmark

Sabrina Meisgen (Sweden)

P08-2 - Trends in COPD Pharmacotherapy in Norway, 2013–2022: A Nationwide Prescription Study

Kristian Svendsen (Norway)

P08-3 - Risk factors for mortality during first COPD exacerbation hospitalisation differ by sex: a Danish nationwide cohort study

Mathias Therkelsen King (Denmark)

P08-4 - Association between comorbidity clusters and three-year mortality following first hospital contact for chronic obstructive pulmonary disease

Sebastian T.E. Buchardt (Denmark)

P08-5 - Mepolizumab reduces systemic corticosteroid utilization in chronic obstructive pulmonary disease: post-hoc analysis of the phase III MATINEE study

Johanna Sulku (Sweden)

Poster round 9 - Thoracic ultrasound and mediastinal cryobiopsy

Chair: Sólrún Björk Rúnarsdóttir

P09-1 - Beyond the lung parenchyma: diaphragmatic ultrasound in fibrosing interstitial lung disease — A systematic review.

Sanjeewa Patabendige (Denmark)

P09-2 - Thoracic ultrasound shear wave elastography in fibrosing interstitial lung disease compared with healthy controls.

Sanjeewa Patabendige (Denmark)

P09-3 - Normal values for shear wave elastography of the lungs in healthy adults: A prospective cohort study

Rasmus Larsen (Denmark)

P09-4 - Thoracic Ultrasound Findings in Healthy Adults: B-Lines, Pleural Thickness, and Pleural Effusion – A Pilot Study

Berkay Adam Yüksel (Denmark)

P09-5 - Incremental value and optimal sampling number in transbronchial mediastinal cryobiopsy: interim results from the MECRIS study

Ilias Lyroudis (Sweden)

Silfurberg A

Session 16

The role of screening for obstructive diseases and treatment adherence

Chair I: Brynja Jónsdóttir (Iceland)

Chair II: Rune Nielsen (Norway)

15:00- 15:20  

How Common Is Obstructive Sleep Apnea in the General Population? Is It Time to Start General Screening?

Elín Helga Þórarinsdóttir (Iceland)

15:20-15:40

Results from the BreatheIn asthma 

Kristina Kock Hansen (Denmark)

15:40-16:00

Results from the BreatheIn COPD  

Anders Løkke ( Denmark)

 16:00 - 16:20

Web-Based COPD Risk Self-Assessment

Bernt Bøgvald Aarli (Norway)

Silfurberg B

Session 17

Chronic cough

Chair I: Össur Ingi Emilsson (Iceland)

Chair II: Mirjam Ljungren (Sweden)

 15:00 - 15:30

Defining chronic cough – is there a need for change?

Anne Lätti (Finland)

15:30– 16:00

Current standards in the treatment of cough

Össur Ingi Emilsson (Iceland), Henrik Johansson (Sweden)

16:00 - 16:30

NeuroCough: New insights in chronic cough from multi-center registries

Lorcan McGarvey (Ireland)

Kaldalón

Session 18

Sleep and respiration in Neuromuscular diseases

Chair I: Sólrún Björk Rúnarsdóttir (Iceland)

Chair II: Anna Louise Kleiven (Norway)

15:00- 15:20

Tracing History Through Registers: A Retrospective Inquiry

Andreas Palm (Sweden)

15:20-15:40

Sleep and breathing in neuromuscular diseases

Sigurd Aarrestad (Norway)

15:40-16:00

Use of  mechanical insufflation/ exsufflation in patients with neuromuscular diseases

Tiina Andersen (Norway)

16:00-16:20

LTMV in NMD invasive vs non-invasive (indications/
advantages/ disadvantages

Anita Simmonds (England)

RÍMA

Oral session 3

Infection/ILD/Cancer

Chair 1: Paula Kauppi (Finland)

Chair 2: Sif Hansdóttir (Iceland)

15:00-15:10

Inhaled corticosteroids and risk of non-tuberculous mycobacteria in patients with chronic obstructive pulmonary disease

Pradeesh Sivaplan, Copenhagen REspiratory Research, Department of Medicine, Herlev Gentofte Hospital

15:10-15:20  

PNEUMO Study in Finland – preliminary results

Hanna-Riikka Kreivi, Helsinki University Hospital

15:20-15:30

Serum KL-6 levels correlate with fibrosis and disease outcome in patients with pulmonary alveolar proteinosis (PAP)

Francesco Bonella Ruhrlandklinik University Hospital Essen

15:30-15:40  

Serum precipitins as predictors of mortality in hypersensitivity pneumonitis: a double-center retrospective observational study

Francesco Bonella Ruhrlandklinik University Hospital Essen

15:40-15:50

Implementing tarlatamab in routine practice: a protocol-driven pathway with risk-aligned monitoring and service impact

Sanya Arora, The London Clinic

15:50-16:0

Self-reported witnessed episodes of apnea during sleep is associated with Incident lung and breast cancer

Karl A Franklin, Umeå University Hospital

Silfurberg A

Session 19

What is happening in the Nordics and Europe- Scientific researches

Chair I: Þórarinn Gíslason (Iceland)

Chair II: Christer Jansson (Sweden)

08:30 - 08:50

Burden of obstructive lung disease - BOLD/

André Amaral (England)

08:50 - 09:10

Burden beyond the lungs: patient-reported  experiences of COPD in five European countries

Anders Løkke (Denmark)

09:10 - 09:30

SCAPIS project

Andrei Malinovschi (Sweden)

09:30 - 09:50

Hypoxic pulmonary vasoconstriction as a driver of cardiopulmonary disease – Steps towards identification of novel targets for treatment of COPD

Rainer Böger ( Germany)

Silfurberg B

Session 20

Tobacco prevention

Chair I: Jónína Sigurgeirsdóttir (Iceland)

Chair II: Steinn Jónsson (Iceland)

08:30-09:00

The new nicotine epidemic

Charlotta Pisinger (Denmark)

09:00-09:30

Health effects of novel nicotine products

Magnus Lundbäck (Sweden)

09:30-10.00

The role of Dentistry in Clinical Nicotine Prevention in Sweden and opportunities in other Nordic countries 

Ásgeir Rúnar Helgason (Iceland)

Kaldalón

Physiotherapy Session A

Breathing exercises and mobilization; for whom, how and why?

Chair I: Ragnheiður Harpa Arnardóttir (Iceland)

Chair II: Ólöf  Ragna Ámundadóttir (Iceland)

08:30-08:50

Clinical reasoning in respiratory physiotherapy

Monika Fagevik Olsén (Sweden)

08:50-09:10

Early mobilization after abdominal and cardiothoracic surgery

Monika Fagevik Olsén (Sweden)

09:10-09:30

PEP: History, applications and physiological effects

Monika Fagevik Olsén (Sweden)

09:30-09:50

Revisiting assumptions about the dependent-lung ventilation during airway clearance techniques: did we target the wrong lung

William Poncin (Belgium)

09:50-10:00

Panel discussion

Poster round 10 - Hypoxia and burden of COPD

Chair:  Friðrik Yngvason

P10-1 - Adaptation of the lung circulation to high altitude hypoxia: Role of the DDAH-1 and -2 genes. ALTIGENE – A Mendelian-randomized study at 3,450 m

Juliane Hannemann (Germany)

P10-3 - Burden beyond the lungs: Patient-reported experiences of COPD in five North European countries

Anders Løkke (Denmark)

P10-4 - Assessment of anxiety in COPD: A scoping review of questionnaires

Camilla Fischer Christiansen (Denmark)

P10-5 - Increased hospitalisation and mortality risk in patients with GOLD A COPD compared with the general population- results from the PRAXIS-study

Åsa Athlin (Sweden)

Poster round 11 - Asthma – Healthcare cost and societal burden

Chair: Vibeke Backer

P11-1 - FINASTHMA cost: Adherence and persistence to biological asthma treatments in Finland between 2020–2023

Arja Viinanen (Finland)

P11-2 - Costs associated with oral corticosteroid use in Finnish asthma patients –A retrospective registry study (FINASTHMA cost)

Hanna Hisinger-Mölkänen (Finland)

P11-3 - Burden of asthma and related societal costs in Sweden: a national web-based survey study

Björn Stridh (Sweden)

P11-4 - Productivity loss associated with chronic cough in working Swedish adults

Össur Ingi Emilsson (Iceland)

Poster round 12 - Respiratory infections

Chair:  Paula Kauppi

P12-1 - Healthcare and socioeconomic costs associated with pneumonia: A nationwide matched cohort study from 2002 to 2016

Melina Gade Sikjær (Denmark)

P12-2 - Real-World Evidence of the Adjuvanted-RSVPreF3 Vaccine’s Uptake and Effectiveness among COPD Patients in Denmark: A Nationwide Cohort Study

Hans-Jakob Herbst Sørensen (Denmark)

P12-3 - Sex differences in exacerbations and symptom burden in non-cystic fibrosis bronchiectasis: findings from the Bronchiectasis Health Questionnaire

Line Birk Bos (Denmark)

P12-4 - Impact of chronic rhinosinusitis on COVID-19 severity: findings from a register-based study of 7.9 million individuals

Daniil Lisik (Sweden)

P12-5 - Transthoracic drainage of lung abscesses (TOLA): Protocol for a national multicenter randomized open label trial

Katrine Kristensen (Denmark)

Silfurberg A

Session 22

Cutting-edge Insights from the European Clinical Respiratory Journal: The Year's Most Influential Scientific Papers

Chair: Vasiliki Panou (Denmark)

10:30-10:35

Opening

10:35-10:45

Pulmocardiology / Lung Transplantation

Hans Henrik Schultz (Denmark)

10:45-10:55

COPD

Pradeesh Sivapalan (Denmark)

10:55-11:05

ILD

Saher Shaker (Denmark)

11:05-11:15

Hypoxia/Hypercapnia

Charlotte Schou (Denmark)

11:15-11:25

Sleep Apnoea

Karl Franklin (Sweden)

11:25-11:35

Invasive Pulmonology

Hrönn Harðardóttir (Iceland)

11:35-11:45

Asthma

Prof. Charlotte S. Ulrik

11:45-12:00

Panel Discussion

Silfurberg B

Session 23

Interstitial lung diseases

Chair I: Gunnar Gudmundsson (Iceland)

Chair II: Phuong Phuong Diep (Norway)

10:30-11:00

CTD-ILD

Elisabeth Bendstrup (Denmark)

11:00-11:30

Early and familial pulmonary fibrosis

Matt Hunninghake (USA)

11:30-12:00

Sarcoidosis

Tomas Eagan (Norway)

Kaldalón

Physiotherapy Session B

Physical training in COPD and asthma, various approaches

Chair I: Vibeke Backer (Denmark)

Chair II: Ragnheiður Harpa Arnardóttir (Iceland)

10:30-11:00

Physical training in asthma and COPD

Margareta Emtner (Sweden)

11:00-11:20

Is HIT a HIT in COPD?

André Nyberg (Sweden)

11:20-11:40

Oxygen on the Move: Optimising Oxygenation to Improve Functional Performance in COPD

Linette Marie Kofod (Denmark)

11:40-12:00

Panel discussion

Ríma

Oral session 4
Asthma/Sleep apnea – Young researchers

Chair I: Alan Altraja (Estonia)

Chair II: Benedikt Friðriksson (Iceland)

10:30-10:40

Allergen-Specific Immunoglobulin E and Outcomes in Adult-Onset Asthma

Ella Flinkaman, Faculty of Medicine and Health Technology, Tampera University

10:40-10:50

Impact of aging on high-dose inhaled corticosteroid use and specialist care management in patients with asthma – a Danish nationwide cohort study

Alma Holm Rovsing, Department of Respiratory Medicin, Copenhagen University Hospital- Hvidovre

10:50-11:00

Childhood asthma exacerbation phenotypes
predict exacerbation risk in adulthood: a 20-year population-based study

Stina Selberg, Umeå University

11:00-11:10

Effects of clinical allergy on high Type-2 inflammatory status

Selin Ercan, Krefting Research Centre, Institute of Medicine, Salhgrenska Academy, University of Gothenburg

11:10-11:20

Register study comparing adherence to oral treatments in asthma and cardiometabolic diseases

Caroline Ahlroth Pind, Department of Medical Sciences, Lung, allergy-and sleep research, Uppsala University

11:20-11:30

Sex differences in objectively measured sleep and sleep apnea in a community-based context.

Galileo Frustaci, Department of Medical Sciences, Respiratory, Allergy and Sleep Research, Uppsala University